医美龙头押注“核酸药物第一股” 跨界布局藏何深意?

21世纪经济报道
Sep 10

21世纪经济报道记者韩利明  9月10日早间开盘一小时内,圣诺医药(02257.HK)股价上涨7.18%至22.1港元/股。回溯近期股价表现,圣诺医药9月8日涨幅达22.78%,报18.38港元/股收盘;9月9日股价再次上涨12.19%,最终以20.62港元/股收盘。  在这背后,一则融资公告或成关键推手。9月8日,圣诺医药公告称,已与4名认购人订立协议,按每股12港元的价格认购圣诺医药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10